Jonathan Kell
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 41
- Acute Myeloid Leukemia Research 37
- Multiple Myeloma Research and Treatments 9
-
- Acute Lymphoblastic Leukemia research 17
- Co-authors
- Alan K. Burnett (20 shared papers)Nigel H. Russell (18 shared papers)Robert K. Hills (16 shared papers)Keith Wheatley (6 shared papers)Lars Kjeldsen (8 shared papers)Donald Milligan (8 shared papers)Ann Hunter (5 shared papers)Richard E. Clark (9 shared papers)
- Journals
- Blood (12 papers)British Journal of Haematology (6 papers)Journal of Clinical Oncology (5 papers)Leukemia Research (3 papers)Leukemia (3 papers)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Jonathan Kell
56 papers receiving 2.4k citations
Jonathan Kell's Hit Papers
Peers
Comparison fields: 5 of 88
- Hematology 1.9k
- Genetics 392
- Public Health, Environmental and Occupational Health 683
- Biochemistry 133
- Oncology 574
Countries citing papers authored by Jonathan Kell
This map shows the geographic impact of Jonathan Kell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Kell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Kell more than expected).
Fields of papers citing papers by Jonathan Kell
This network shows the impact of papers produced by Jonathan Kell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Kell. The network helps show where Jonathan Kell may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Kell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial Hit paper breakdown → | 2010 | 490 |
| 2 | Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial Hit paper breakdown → | 2015 | 346 |
| 3 | 2012 | 293 | |
| 4 | 2015 | 194 | |
| 5 | 2006 | 129 | |
| 6 | 2010 | 125 | |
| 7 | 2006 | 102 | |
| 8 | 2008 | 71 | |
| 9 | 2013 | 63 | |
| 10 | 2009 | 58 | |
| 11 | 2016 | 56 | |
| 12 | 2012 | 53 | |
| 13 | 2012 | 42 | |
| 14 | 2009 | 37 | |
| 15 | 2011 | 35 | |
| 16 | 2006 | 26 | |
| 17 | 2006 | 23 | |
| 18 | 2020 | 20 | |
| 19 | 2004 | 20 | |
| 20 | 2020 | 19 |
About Jonathan Kell
Jonathan Kell is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Genetics, having authored 57 papers that have together received 2.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (37 papers), Acute Lymphoblastic Leukemia research (17 papers), Retinoids in leukemia and cellular processes (12 papers), Multiple Myeloma Research and Treatments (9 papers), Cancer survivorship and care (7 papers), Neutropenia and Cancer Infections (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (392 citations), Public Health, Environmental and Occupational Health (683 citations), Biochemistry (133 citations) and Oncology (574 citations). Jonathan Kell has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Keith Wheatley, Lars Kjeldsen, Donald Milligan, Ann Hunter, Richard E. Clark, Anthony H. Goldstone and John A. Liu Yin. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia Research and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.